ALINA BOSHAKOVA: Open Payments
NPI 1356656763 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 37 payments from 11 companies in 2025. Trend: 2023 $877 · 2024 $857 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $429 |
| Aimmune Therapeutics, Inc. | 7 | $292 |
| Ardelyx, Inc. | 4 | $219 |
| ABBVIE INC. | 9 | $171 |
| Axsome Therapeutics, Inc. | 3 | $160 |
| Amgen Inc. | 3 | $69 |
| Viatris Specialty LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: REXULTI, ZENPEP, IBSRELA, Auvelity, LINZESS, OTEZLA, CREON, YUPELRI.
Industry payments across NY — which companies pay providers there.
